Total laparoscopic hysterectomy: Removal of uterus and cervix by laparoscope
Study summary
The goal of this clinical trial is to compare the laparoscopic and transvaginal closure techniques of the vaginal vault in patients who perform TLH, regarding the risk of vaginal vault hematoma and other complications as vaginal cuff infection and sexual dysfunction.
Eligibility
Sex
FEMALE
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Adult females consenting to do TLH all age groups with diagnoses of benign uterine conditions.
* Women who are non-obese (normal or overweight women with BMI range 18-29.9).
* Sexually active female.
Exclusion Criteria:
* Diagnosed cases of pelvic malignancy
* Diagnosed patients with Cervical intraepithelial neoplasia (CIN) or bacterial vaginosis (any infection should be treated)
* Obese patients.
* Patients currently undergoing treatment for any type of cancer
* Patients with coagulopathy, bleeding/clotting disorders
* Patients with any condition can impair wound healing: diabetes mellites, anemia, steroids
* Patients with a previous history of radiation and allergy to sutures
* Patients with clinically evident prolapse
Primary outcome measure(s)
Vaginal Vault hematoma — From 10 days postoperative to 30 days postoperative It will be assessed by examination and ultrasound
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.